United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$1.65B
↑ 75% above average
Average (9y)
$945.44M
Historical baseline
Range
High:$1.65B
Low:$-74.90M
CAGR
+4.8%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $1.65B | +19.3% |
| 2023 | $1.39B | +33.3% |
| 2022 | $1.04B | +41.2% |
| 2021 | $736.80M | +14.0% |
| 2020 | $646.30M | +962.9% |
| 2019 | $-74.90M | -108.9% |
| 2018 | $838.40M | -20.4% |
| 2017 | $1.05B | -3.4% |
| 2016 | $1.09B | +0.8% |
| 2015 | $1.08B | - |